Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
1 | Adrenergic signaling in cardiomyocytes |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
2 | Calcium signaling pathway |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
3 | cAMP signaling pathway |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
4 | cGMP-PKG signaling pathway |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
5 | Cortisol synthesis and secretion |
[1] KCNA4 | D10228 | Amifampridine | [3] 3, 11, 12 |
6 | Cushing syndrome |
[1] KCNA4 | D10228 | Amifampridine | [3] 3, 11, 12 |
7 | Neuroactive ligand-receptor interaction |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
8 | Regulation of lipolysis in adipocytes |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
9 | Renin secretion |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
10 | Salivary secretion |
[1] ADRB2 | D02147 | Salbutamol | [13] 3, 11, 12, 13, 49, 85, 86, 89, 113, 228, 231, 256, 299 |
11 | Serotonergic synapse |
[1] KCND2 | D10228 | Amifampridine | [3] 3, 11, 12 |